NCT00277121

Brief Summary

Several lipid disorders are without known genetic origin. The scope of this project is to sequence genes superior involved in lipid and carbohydrate metabolism in patients with severe lipid disorders. The resulting mutations will be tested in suitable in vitro systems to detect their part in development of the specific disease.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 12, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 13, 2006

Completed
Last Updated

January 13, 2006

Status Verified

January 1, 2006

First QC Date

January 12, 2006

Last Update Submit

January 12, 2006

Conditions

Keywords

Lipid disorderGene mutation

Eligibility Criteria

Age18 Years - 54 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • proven written informed consent prior to recruitment
  • male or female
  • years old
  • patients with severe lipid disorders
  • fasting plasma cholesterol, triglyceride or glucose, blood pressure or waist circumference/BMI out of normal range

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Nutrition, University of Oslo

Oslo, NO-0316, Norway

Location

MeSH Terms

Conditions

Lipid Metabolism Disorders

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Hilde I Nebb, PhD

    Department of Nutrition, University of Oslo

    STUDY CHAIR
  • Karianne Solaas, PhD

    Department of Nutrition, University of Oslo

    PRINCIPAL INVESTIGATOR
  • Monica H Carlsen

    Department of Nutrition, University of Oslo

    PRINCIPAL INVESTIGATOR
  • Leiv Ose, Dr med

    Lipid Clinic, The National Hospital

    PRINCIPAL INVESTIGATOR
  • Marit S Nenseter, PhD

    Research Institute of Internal Medicine, The National Hospital

    PRINCIPAL INVESTIGATOR
  • Kirsten Holven, PhD

    Research Institute of Internal Medicine, The National Hospital

    PRINCIPAL INVESTIGATOR
  • Bente Halvorsen, PhD

    Research Institute of Internal Medicine, The National Hospital

    PRINCIPAL INVESTIGATOR
  • Serena Tonstad, Dr med

    Department of Preventive Medicine, Ullevål university hospital

    PRINCIPAL INVESTIGATOR
  • Håkon Gjessing, PhD

    Norwegian Institute of Public Health

    PRINCIPAL INVESTIGATOR
  • Per Thorsby, Dr med

    Hormone laboratory, Aker university hospital

    PRINCIPAL INVESTIGATOR
  • Sigbjørn Lien, PhD

    Agricultural university of Norway

    PRINCIPAL INVESTIGATOR
  • Paul Berg, PhD

    Agricultural university of Norway

    PRINCIPAL INVESTIGATOR
  • Kjetil Retterstøl, Dr med

    Lipid Clinic, The National Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hilde Irene Nebb, PhD

CONTACT

Kjetil Retterstøl, Dr Med

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 12, 2006

First Posted

January 13, 2006

Study Start

January 1, 2006

Last Updated

January 13, 2006

Record last verified: 2006-01

Locations